Inventor
MURPHY ANDREW J
US349 patents
⚠️ This page may combine multiple inventors who share the name “MURPHY ANDREW J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
39 patentsUS9987500B2Jun 5, 2018
Human antibodies to PD-1
REGENERON PHARMA126 citations99
US9006511B2Apr 14, 2015
Human lambda light chain mice
REGENERON PHARMA45 citations99
US8697940B2Apr 15, 2014
ADAM6 mice
REGENERON PHARMA114 citations99
US7105348B2Sep 12, 2006
Methods of modifying eukaryotic cells
REGENERON PHARMA355 citations99
US6596541B2Jul 22, 2003
Methods of modifying eukaryotic cells
REGENERON PHARMA996 citations99
US6586251B2Jul 1, 2003
Methods of modifying eukaryotic cells
REGENERON PHARMA505 citations99
US10412940B2Sep 17, 2019
Mice expressing a limited immunoglobulin light chain repertoire
REGENERON PHARMA38 citations98
US9932408B2Apr 3, 2018
ADAM6 mice
REGENERON PHARMA22 citations98
US9540449B2Jan 10, 2017
Anti-PCSK9 antibodies with pH-dependent binding characteristics
REGENERON PHARMA57 citations98
US9453072B2Sep 27, 2016
Anti-IL-33 antibodies
REGENERON PHARMA49 citations98
US9226484B2Jan 5, 2016
Human lambda light chain mice
REGENERON PHARMA31 citations98
US9206263B2Dec 8, 2015
Method of making antibodies using a human lambda light chain mouse
REGENERON PHARMA33 citations98
US9163092B2Oct 20, 2015
Hybrid light chain mice
REGENERON PHARMA36 citations98
US9150662B2Oct 6, 2015
Hybrid light chain mice
REGENERON PHARMA31 citations98
US9079948B2Jul 14, 2015
Human antibodies to Fel d1 and methods of use thereof
REGENERON PHARMA83 citations98
US9066502B2Jun 30, 2015
Hybrid light chain mice
REGENERON PHARMA36 citations98
US9029628B2May 12, 2015
Human lambda light chain mice
REGENERON PHARMA37 citations98
US8847005B2Sep 30, 2014
Genetically modified major histocompatibility complex mice
REGENERON PHARMA33 citations98
US9637535B2May 2, 2017
IL-33 antagonists and uses thereof
REGENERON PHARMA36 citations97
US9462794B2Oct 11, 2016
Non-human animals having a humanized signal-regulatory protein gene
REGENERON PHARMA28 citations97
US9193977B2Nov 24, 2015
Non-human animals having a humanized signal-regulatory protein gene
REGENERON PHARMA29 citations97
US9127292B2Sep 8, 2015
Non-human animals having a humanized signal-regulatory protein gene
REGENERON PHARMA28 citations97
US9113616B2Aug 25, 2015
Genetically modified mice having humanized TCR variable genes
REGENERON PHARMA67 citations97
US8878001B2Nov 4, 2014
Humanized IL-6 and IL-6 receptor
REGENERON PHARMA38 citations97
US9206262B2Dec 8, 2015
Method of cloning a lambda light chain variable domain using a human lambda light chain mouse
REGENERON PHARMA20 citations96
US9206261B2Dec 8, 2015
Method of making antibodies using a human lambda light chain mouse
REGENERON PHARMA19 citations96
US10905109B2Feb 2, 2021
ADAM6 mice
REGENERON PHARMA10 citations94
US10694725B2Jun 30, 2020
ADAM6 mice
REGENERON PHARMA15 citations94
US10577430B2Mar 3, 2020
ADAM6 mice
REGENERON PHARMA15 citations94
US10561124B2Feb 18, 2020
Humanized light chain mice
REGENERON PHARMA12 citations94
US9944716B2Apr 17, 2018
ADAM6 mice
REGENERON PHARMA17 citations94
US9938345B2Apr 10, 2018
Human antibodies to PD-L1
REGENERON PHARMA37 citations94
US9796788B2Oct 24, 2017
Mice expressing a limited immunoglobulin light chain repertoire
REGENERON PHARMA26 citations94
US9334334B2May 10, 2016
Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same
REGENERON PHARMA31 citations94
US9301510B2Apr 5, 2016
Mice that produce antigen-binding proteins with pH-dependent binding characteristics
REGENERON PHARMA28 citations94
US9204624B2Dec 8, 2015
Non-human animals with modifed immunoglobulin heavy chain sequences
REGENERON PHARMA30 citations94
US9043996B2Jun 2, 2015
Genetically modified major histocompatibility complex animals
REGENERON PHARMA31 citations94
US10676530B2Jun 9, 2020
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor
REGENERON PHARMA14 citations93
US10669341B2Jun 2, 2020
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor
REGENERON PHARMA13 citations93
MACDONALD LYNN
4 patentsUS8754287B2Jun 17, 2014
Mice that make heavy chain antibodies
MACDONALD LYNN159 citations99
US8642835B2Feb 4, 2014
ADAM6 mice
MACDONALD LYNN133 citations99
US9035128B2May 19, 2015
Hybrid light chain mice
MACDONALD LYNN59 citations98
US9012717B2Apr 21, 2015
Human lambda light chain mice
MACDONALD LYNN61 citations98
MURPHY ANDREW J
2 patentsCADUS PHARMACEUTICAL CORP
2 patentsSLEEMAN MARK W
1 patentSTEVENS SEAN
1 patentECONOMIDES ARIS N
1 patentShowing the top 50 of 349 patents by PatentIndex Score.